{"disease":{"id":"dementia-alzheimer-type","name":"dementia alzheimer type"},"drugs":{"marketed":[{"drug_id":"donepezil-hydrochloride","indication_name":"Dementia of the Alzheimer's type","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"DONEPEZIL HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":28,"revenue":null,"mechanism":null},{"drug_id":"galantamine","indication_name":"Mild to moderate dementia of the Alzheimer's type","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Razadyne","generic_name":"GALANTAMINE","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"Acetylcholinesterase","drug_class":"Cholinesterase Inhibitor","quality_score":62,"revenue":null,"mechanism":"Razadyne works by blocking the enzyme that breaks down acetylcholine, allowing more of this neurotransmitter to be available in the brain."},{"drug_id":"galantamine-hydrobromide","indication_name":"Mild to moderate dementia of the Alzheimer's type","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"GALANTAMINE HYDROBROMIDE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":31,"revenue":null,"mechanism":null},{"drug_id":"benzgalantamine","indication_name":"mild to moderate dementia of the Alzheimer's type","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zunveyl","generic_name":"BENZGALANTAMINE","company_name":"Alpha Cognition","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":56,"revenue":null,"mechanism":"Zunveyl works by enhancing communication between brain cells, specifically by stimulating cholinergic receptors."}],"pipeline":[],"offLabel":[],"totalMarketed":4,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05796037","title":"An Observational Study of Patients Living With Chronic Neurological Diseases","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1500000,"lead_sponsor_name":"Target PharmaSolutions, Inc.","has_results":false},{"nct_id":"NCT07205978","title":"Nut Consumption and Prevention of Non-communicable Diseases: A Global Individual Participant Data Meta-analysis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1000000,"lead_sponsor_name":"Institut Investigacio Sanitaria Pere Virgili","has_results":false},{"nct_id":"NCT06719453","title":"Prevalence of Alzheimer's Disease Pathology in the Community","phase":"","overall_status":"COMPLETED","enrollment_count":9663,"lead_sponsor_name":"Helse Stavanger HF","has_results":false},{"nct_id":"NCT04680013","title":"Genetic Studies in Familial Dementia","phase":"","overall_status":"COMPLETED","enrollment_count":4884,"lead_sponsor_name":"University of Miami","has_results":false},{"nct_id":"NCT02446132","title":"Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":1197,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT05052450","title":"Factors Associated With Mortality, Morbidity and Prognosis in Dementia Patients","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Gulhane Training and Research Hospital","has_results":false},{"nct_id":"NCT03393520","title":"Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":601,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":false},{"nct_id":"NCT04488419","title":"ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":554,"lead_sponsor_name":"LeonaBio","has_results":true},{"nct_id":"NCT05893524","title":"Uppsala-Dalarna Dementia and Gait Project","phase":"","overall_status":"RECRUITING","enrollment_count":550,"lead_sponsor_name":"Dalarna University","has_results":false},{"nct_id":"NCT04863495","title":"Couples Lived Experience","phase":"","overall_status":"COMPLETED","enrollment_count":544,"lead_sponsor_name":"NYU Langone Health","has_results":false},{"nct_id":"NCT02442778","title":"Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Participants With Dementia of the Alzheimer's Type","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":522,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT04947553","title":"A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":456,"lead_sponsor_name":"Axsome Therapeutics, Inc.","has_results":false},{"nct_id":"NCT05923307","title":"Multifactorial Approach to Dementia, Multicentric Study","phase":"","overall_status":"UNKNOWN","enrollment_count":450,"lead_sponsor_name":"Daniel Serrani Azcurra","has_results":false},{"nct_id":"NCT04428112","title":"Rural Dementia Caregiver Project","phase":"NA","overall_status":"COMPLETED","enrollment_count":418,"lead_sponsor_name":"University of California, San Francisco","has_results":true},{"nct_id":"NCT03620981","title":"Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":410,"lead_sponsor_name":"Otsuka Pharmaceutical Co., Ltd.","has_results":true},{"nct_id":"NCT05557409","title":"A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":408,"lead_sponsor_name":"Axsome Therapeutics, Inc.","has_results":false},{"nct_id":"NCT02442765","title":"Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":387,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT03226522","title":"Addressing Dementia Via Agitation-Centered Evaluation","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":366,"lead_sponsor_name":"Axsome Therapeutics, Inc.","has_results":true},{"nct_id":"NCT05973448","title":"The Nightlight Falls Prevention Study","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":335,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false},{"nct_id":"NCT07037550","title":"Effectiveness of Strength-based Intervention for Elderly With Dementia Living in the Community","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":272,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT03875326","title":"Stimulation to Improve Memory","phase":"NA","overall_status":"COMPLETED","enrollment_count":269,"lead_sponsor_name":"University of Michigan","has_results":false},{"nct_id":"NCT04464564","title":"Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":241,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT03721705","title":"Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":190,"lead_sponsor_name":"Renew Research, LLC","has_results":true},{"nct_id":"NCT02727699","title":"A Phase II Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to AD (XanADu)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":185,"lead_sponsor_name":"Actinogen Medical","has_results":true},{"nct_id":"NCT04408755","title":"Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":184,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT07485387","title":"Global Collaborative Research on Establishing a Korean Cognitive Aging Cohort","phase":"","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"Korea University","has_results":false},{"nct_id":"NCT03153371","title":"Early-onset Alzheimer's Disease Phenotypes: Neuropsychology and Neural Networks","phase":"","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT04797715","title":"Assessing Clinical Outcomes in Alzheimer's Disease Agitation","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":178,"lead_sponsor_name":"Axsome Therapeutics, Inc.","has_results":false},{"nct_id":"NCT03724942","title":"Brexpiprazole for the Long-term Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":164,"lead_sponsor_name":"Otsuka Pharmaceutical Co., Ltd.","has_results":true},{"nct_id":"NCT07115251","title":"Plans4Care: Personalized Dementia Care on Demand","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":160,"lead_sponsor_name":"Plans4Care Inc","has_results":false},{"nct_id":"NCT04851691","title":"An Electronic Clinical Decision Support Tool to Reduce Low-value Antipsychotic Prescriptions","phase":"NA","overall_status":"COMPLETED","enrollment_count":158,"lead_sponsor_name":"University of California, Los Angeles","has_results":true},{"nct_id":"NCT04818255","title":"STIM+: PET Biomarker Education & Disclosure","phase":"NA","overall_status":"COMPLETED","enrollment_count":152,"lead_sponsor_name":"University of Michigan","has_results":true},{"nct_id":"NCT02168920","title":"Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":150,"lead_sponsor_name":"Otsuka Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT04956549","title":"Reducing African American's Alzheimer's Risk Through Exercise-Mild Cognitive Impairment (RAATE-MCI)","phase":"NA","overall_status":"RECRUITING","enrollment_count":144,"lead_sponsor_name":"Pennington Biomedical Research Center","has_results":false},{"nct_id":"NCT06736509","title":"An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":139,"lead_sponsor_name":"Axsome Therapeutics, Inc.","has_results":false},{"nct_id":"NCT06292351","title":"DMB-I in the Treatment of Alzheimer Type Dementia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":133,"lead_sponsor_name":"Bigespas LTD","has_results":false},{"nct_id":"NCT05860127","title":"Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":133,"lead_sponsor_name":"University of Massachusetts, Amherst","has_results":true},{"nct_id":"NCT05394584","title":"CST-HK for Cognition and Well-being in People With Dementia","phase":"NA","overall_status":"COMPLETED","enrollment_count":129,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT06565169","title":"Improving PCP Advance Care Planning for People With ADRD","phase":"NA","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"University of Pittsburgh","has_results":false},{"nct_id":"NCT04969796","title":"REACH Hope Intervention for Dementia and TBI Caregivers","phase":"NA","overall_status":"UNKNOWN","enrollment_count":110,"lead_sponsor_name":"Memphis VA Medical Center","has_results":false},{"nct_id":"NCT03622814","title":"Partners at Meals - Respite Care and Home (PAM)","phase":"NA","overall_status":"COMPLETED","enrollment_count":106,"lead_sponsor_name":"Medical University of South Carolina","has_results":true},{"nct_id":"NCT05232526","title":"Imagery in Early Stages of Dementia","phase":"NA","overall_status":"UNKNOWN","enrollment_count":105,"lead_sponsor_name":"University of West Attica","has_results":false},{"nct_id":"NCT07064226","title":"Validation of a Digital Intervention to Rehabilitate Cognitive Resources","phase":"NA","overall_status":"RECRUITING","enrollment_count":102,"lead_sponsor_name":"Fondazione Don Carlo Gnocchi Onlus","has_results":false},{"nct_id":"NCT03672266","title":"Studies of Brain and Body Interaction","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Rutgers University","has_results":false},{"nct_id":"NCT03991195","title":"Intervention of Intestinal Microorganism in Mild Cognitive Impairment","phase":"NA","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"XuanwuH 2","has_results":false},{"nct_id":"NCT03846492","title":"Targeting Brain Physiology to Treat Neuropsychiatric Symptoms of Dementia Using TMS-EEG and tDCS","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":90,"lead_sponsor_name":"Centre for Addiction and Mental Health","has_results":false},{"nct_id":"NCT04491006","title":"A Study of ATH-1017 in Mild to Moderate Alzheimer's Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":77,"lead_sponsor_name":"LeonaBio","has_results":true},{"nct_id":"NCT02322021","title":"Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":70,"lead_sponsor_name":"Eisai Inc.","has_results":true},{"nct_id":"NCT05113732","title":"Association of Cognition With Functional Mobility in People With Alzheimer's Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":64,"lead_sponsor_name":"Istanbul University - Cerrahpasa","has_results":false},{"nct_id":"NCT04981587","title":"Effects of Strength Exercise on Fall Risk in Elderly With Alzheimer's Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"University of Jaén","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}